SCP Platform
Alzheimer's Disease / Neurodegeneration
PreclinicalActive
Key Facts
Indication
Alzheimer's Disease / Neurodegeneration
Phase
Preclinical
Status
Active
Company
About Lateral Pharma
An Australian biotech developing first-in-class LanCL-targeting therapies for neuropathic pain, neurodegeneration, and healthy ageing.
View full company profileAbout Lateral Pharma
An Australian biotech developing first-in-class LanCL-targeting therapies for neuropathic pain, neurodegeneration, and healthy ageing.
View full company profileAbout Lateral Pharma
An Australian biotech developing first-in-class LanCL-targeting therapies for neuropathic pain, neurodegeneration, and healthy ageing.
View full company profileTherapeutic Areas
Other Alzheimer's Disease / Neurodegeneration Drugs
| Drug | Company | Phase |
|---|---|---|
| ACX-02 | Applied Cognition | Pre-clinical |